LIN CELIA (Chief Medical Officer) received a stock award from VERA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/23/2022ACC: 0001209191-22-047170
Officer· Chief Medical Officer
Since May 2021
+12.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
12.50K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+12.50K
Price / share
—
Trade value
—
% of position
New position
8/19/2022
0.00→12.50K
Total
Net shares
+12.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 8/19/2022 | A · Award | +12.50K | — | — | New position | 0.00 | 12.50K |
| Total | +12.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported